Extract from the Register of European Patents

EP About this file: EP0532369

EP0532369 - Furth therapeutical uses of L-methionine and compositions [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.05.2004
Database last updated on 14.03.2026
Most recent event   Tooltip07.12.2007Lapse of the patent in a contracting state
New state(s): IT
published on 09.01.2008  [2008/02]
Applicant(s)For all designated states
BIOMOX PHARMACEUTICALS (PROPRIETARY) LIMITED
429 Dekgras Road, Silvertondale 0031
Pretoria / ZA
[2004/04]
Former [1993/11]For all designated states
Bissbort, Siegbert Heinrich
387 24th Avenue, Villieria
Pretoria, Transvaal / ZA
For all designated states
Davis, Henry John
Plot 120, Swavelpoort
Pretoria, Transvaal / ZA
Inventor(s)01 / Bissbort, Siegbert Heinrich
387 24th Avenue Villieria
Pretotia, Transvaal / ZA
02 / Davis, Henry John
Plot 120 Swavelpoort
Pretoria, Transvaal / ZA
 [2004/04]
Former [1993/11]01 / see applicant
...
Representative(s)Ellis-Jones, Patrick George Armine, et al
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [1993/11]Ellis-Jones, Patrick George Armine, et al
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5LX / GB
Application number, filing date92308361.214.09.1992
[1993/11]
Priority number, dateZA1991000733313.09.1991         Original published format: ZA 917333
ZA1991000733413.09.1991         Original published format: ZA 917334
ZA1992000366720.05.1992         Original published format: ZA 923667
[1993/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0532369
Date:17.03.1993
Language:EN
[1993/11]
Type: A3 Search report 
No.:EP0532369
Date:19.01.1994
Language:EN
[1994/03]
Type: B1 Patent specification 
No.:EP0532369
Date:02.07.2003
Language:EN
[2003/27]
Search report(s)(Supplementary) European search report - dispatched on:EP01.12.1993
ClassificationIPC:A61K31/195, A61K31/519, A61K31/44, A61K31/714, A61K33/06, A61P31/12, A61P37/00
[2003/01]
CPC:
A61K33/06 (EP,US); A61K31/195 (EP,US); A61K33/10 (EP,US);
A61P31/12 (EP); A61P37/00 (EP)
C-Set:
A61K33/06, A61K2300/00 (US,EP);
A61K33/06, A61K31/714, A61K31/505, A61K31/44 (EP,US);
A61K33/10, A61K2300/00 (US,EP);
A61K33/10, A61K31/714, A61K31/505, A61K31/44 (US,EP)
Former IPC [1993/49]A61K31/195, A61K31/50, A61K31/44, A61K31/68, A61K33/06
Former IPC [1993/11]A61K31/195, // (A61K31/195, 33:06, 31:50, 31:44, 31:68)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1993/11]
TitleGerman:Weitere therapeutische Verwendungen von L-Methionine und Zusammensetzungen[1993/11]
English:Furth therapeutical uses of L-methionine and compositions[1993/11]
French:Utilisations thérapeutiques additionelles de L-méthionine et sa compositions[1993/11]
Examination procedure15.07.1994Examination requested  [1994/36]
21.12.1994Despatch of a communication from the examining division (Time limit: M06)
09.10.1995Reply to a communication from the examining division
13.11.1996Despatch of a communication from the examining division (Time limit: M06)
29.08.1997Reply to a communication from the examining division
18.05.1998Despatch of a communication from the examining division (Time limit: M08)
27.01.1999Reply to a communication from the examining division
16.02.1999Despatch of a communication from the examining division (Time limit: M04)
23.06.1999Reply to a communication from the examining division
13.08.1999Despatch of a communication from the examining division (Time limit: M09)
23.05.2000Reply to a communication from the examining division
22.09.2000Despatch of a communication from the examining division (Time limit: M08)
12.07.2001Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
11.09.2001Reply to a communication from the examining division
12.02.2002Despatch of a communication from the examining division (Time limit: M06)
22.08.2002Reply to a communication from the examining division
28.11.2002Communication of intention to grant the patent
30.04.2003Fee for grant paid
30.04.2003Fee for publishing/printing paid
Opposition(s)05.04.2004No opposition filed within time limit [2004/26]
Request for further processing for:11.09.2001Request for further processing filed
11.09.2001Full payment received (date of receipt of payment)
Request granted
05.11.2001Decision despatched
29.08.1997Request for further processing filed
29.08.1997Full payment received (date of receipt of payment)
Request granted
15.09.1997Decision despatched
09.10.1995Request for further processing filed
09.10.1995Full payment received (date of receipt of payment)
Request deemed not to be filed
31.10.1995Decision despatched
Fees paidRenewal fee
08.09.1994Renewal fee patent year 03
09.11.1995Renewal fee patent year 04
27.09.1996Renewal fee patent year 05
10.09.1997Renewal fee patent year 06
28.09.1998Renewal fee patent year 07
13.09.1999Renewal fee patent year 08
13.11.2000Renewal fee patent year 09
26.10.2001Renewal fee patent year 10
13.11.2002Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
30.09.199504   M06   Fee paid on   09.11.1995
30.09.200009   M06   Fee paid on   13.11.2000
30.09.200110   M06   Fee paid on   26.10.2001
30.09.200211   M06   Fee paid on   13.11.2002
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBE02.07.2003
FR02.07.2003
IT02.07.2003
NL02.07.2003
LU14.09.2003
MC30.09.2003
DK02.10.2003
GR02.10.2003
PT02.10.2003
SE02.10.2003
ES13.10.2003
[2008/02]
Former [2006/14]BE02.07.2003
FR02.07.2003
NL02.07.2003
LU14.09.2003
MC30.09.2003
DK02.10.2003
GR02.10.2003
PT02.10.2003
SE02.10.2003
ES13.10.2003
Former [2005/02]BE02.07.2003
NL02.07.2003
LU14.09.2003
MC30.09.2003
DK02.10.2003
GR02.10.2003
PT02.10.2003
SE02.10.2003
ES13.10.2003
Former [2004/46]BE02.07.2003
NL02.07.2003
LU14.09.2003
DK02.10.2003
GR02.10.2003
PT02.10.2003
SE02.10.2003
ES13.10.2003
Former [2004/39]BE02.07.2003
NL02.07.2003
LU14.09.2003
DK02.10.2003
GR02.10.2003
PT02.10.2003
SE02.10.2003
Former [2004/29]BE02.07.2003
NL02.07.2003
DK02.10.2003
GR02.10.2003
PT02.10.2003
SE02.10.2003
Former [2004/28]BE02.07.2003
NL02.07.2003
GR02.10.2003
PT02.10.2003
SE02.10.2003
Former [2004/16]NL02.07.2003
GR02.10.2003
PT02.10.2003
SE02.10.2003
Former [2004/14]NL02.07.2003
GR02.10.2003
PT02.10.2003
Former [2004/13]NL02.07.2003
PT02.10.2003
Former [2004/10]NL02.07.2003
Documents cited:SearchJP46038591  
   DIALOG INFORMATION SERVICES, file 5: biosis 1969-1992, accession no. 7457100; L. CIOTARU et al.: "Methionine a cell chemical immunostimulator", & REV. MED. INTERNA. NEUROL. PSIHIATR. NEUROCHIR. DERMATO-VENEROL SER DERMATO-VENEROL 34(3), 1989, 161-164
   C. R. ACAD. SC., serie D, vol. 274, no. 10, 6th March 1972, pages 1566-1569, Paris, FR; F. GAUDIN-HARDING et al.: "Nutrition et pathologie exprimentale"
   IMMUNOLOGY, vol. 35, no. 2, 1978, pages 257-256, Blackwell Scientific Publications; G. BOUNOUS et al.: "The effect of dietary amino acids on immune reactivity"
   ANN. NEW YORK ACAD. SCI. vol. 494, 1985, pages 329 - 331 B. COHEN ET AL. 'Methionine and the control of creatine biosynthesis'
   DATABASE WPI Week 7145, Derwent Publications Ltd., London, GB; AN 71-72342S & JP-B-46 038 591 (TAKEDA CHEMICAL INDS. LTD.)
Examination  C. R. ACAD. SC., SERIE D vol. 274, no. 10, 1972, pages 1566 - 1569 F. GAUDIN-HARDING ET AL. 'Nutrition et pathologie exprimentale'
   IMMUNOLOGY vol. 35, no. 2, 1978, pages 257 - 266 G. BOUNOUS ET AL. 'The effect of dietary amino acids on immune reactivity'
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.